We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Digital radiography systems have significant potential to increase the productivity of technologists and lower the dose of radiation experienced by patients, but that potential has not been realized yet, according to a radiology expert.
Drugmakers looking to achieve quality system goals may want to set their sights on configuration management technologies, which are gaining increased acceptance among life science companies.
Because of the unique nature of drug development, pharmaceutical companies are beginning to rely on a mixture of manufacturing solutions -- including lean manufacturing, Six Sigma and process analytical technology (PAT) -- to help streamline operations to achieve higher levels of quality and cost-effectiveness.
Guidant and St. Jude Medical released new trial data last week that could help up the ante in devicemakers’ efforts to expand coverage for defibrillators.
Roche stated last week that it has completed the integration of troubled Disetronic Medical Systems into its operations and is making preparations for an FDA re-audit to resolve good manufacturing practices (GMP) deficiencies discovered within the subsidiary.
A blueprint is emerging for an electronic track-and-trace system that follows pharmaceuticals in the U.S. drug supply chain and combats the counterfeiting of prescription drugs.
Key questions remain unanswered about how an electronic track-and-trace system will work to prevent counterfeit drugs from entering the U.S. supply chain, even as the FDA pushes forward with the initiative, according to experts.
Leading cardiac devicemakers could start seeing higher profits from Medicare reimbursements thanks to a new National Institutes of Health (NIH) study verifying that implantable cardiac defibrillators (ICDs) significantly reduce the number of deaths from heart failure.